Prostate cancer drug Zytiga rejected for use in Ireland

A new prostate cancer treatment has been rejected for use in Ireland.

A new prostate cancer treatment has been rejected for use in Ireland.

Zytiga, which has been dubbed a `wonder drug', can extend the lives of late-stage prostate cancer sufferers.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited